We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$1.28M
Cap. Flow
-$11.4M
Cap. Flow %
-8.5%
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
29
Reduced
140
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.85M
2
ATEC icon
Alphatec Holdings
ATEC
+$2.84M
3
INDV icon
Indivior Pharmaceuticals
INDV
+$2.84M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$2.12M
5
APLS
Apellis Pharmaceuticals
APLS
+$1.76M

Top Sells

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.17M
2
PCRX icon
Pacira BioSciences
PCRX
+$3.36M
3
PFE icon
Pfizer
PFE
+$3.06M
4
UTHR icon
United Therapeutics
UTHR
+$2.79M
5
QURE icon
uniQure
QURE
+$2.06M

Sector Composition

Rank Sector Weight
1 Healthcare 57.92%
2 Real Estate 14.45%
3 Financials 7.05%
4 Industrials 3.2%
5 Technology 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KROS icon
76
Keros Therapeutics
KROS
$211M
$465K 0.35%
+8,000
New +$395K
MDT icon
77
Medtronic
MDT
$106B
$450K 0.33%
5,000
-12,500
-71% -$1.05M
COST icon
78
Costco
COST
$417B
$442K 0.33%
499
-35
-7% -$30.4K
RSG icon
79
Republic Services
RSG
$68.4B
$406K 0.3%
2,020
-138
-6% -$27.8K
ACGL icon
80
Arch Capital
ACGL
$35.4B
$401K 0.3%
3,587
-123
-3% -$12.8K
L icon
81
Loews
L
$23.6B
$392K 0.29%
4,953
-273
-5% -$21.4K
JPM icon
82
JPMorgan Chase
JPM
$907B
$380K 0.28%
1,800
-84
-4% -$17.7K
IEF icon
83
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$375K 0.28%
3,823
-365
-9% -$35.3K
IEI icon
84
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
$374K 0.28%
3,126
-1,060
-25% -$125K
SHY icon
85
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$373K 0.28%
4,482
-2,534
-36% -$209K
CWB icon
86
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$370K 0.28%
4,834
-91
-2% -$6.68K
PFF icon
87
iShares Preferred and Income Securities ETF
PFF
$13.3B
$370K 0.28%
11,136
-21
-0.2% -$676
EMHY icon
88
iShares JPMorgan EM High Yield Bond ETF
EMHY
$613M
$367K 0.27%
9,401
-45
-0.5% -$1.71K
EMB icon
89
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$366K 0.27%
3,908
-65
-2% -$5.92K
INSM icon
90
Insmed
INSM
$23.5B
$365K 0.27%
+5,000
New +$369K
VYM icon
91
Vanguard High Dividend Yield ETF
VYM
$80B
$361K 0.27%
2,815
-121
-4% -$14.9K
PBP icon
92
Invesco S&P 500 BuyWrite ETF
PBP
$348M
$361K 0.27%
15,794
-229
-1% -$5.13K
DWX icon
93
State Street SPDR S&P International Dividend ETF
DWX
$525M
$360K 0.27%
9,375
-589
-6% -$21.8K
DYN icon
94
Dyne Therapeutics
DYN
$3.92B
$359K 0.27%
10,000
-10,000
-50% -$398K
BKLN icon
95
Invesco Senior Loan ETF
BKLN
$7.19B
$358K 0.27%
17,016
+333
+2% +$7K
REM icon
96
iShares Mortgage Real Estate ETF
REM
$559M
$354K 0.26%
14,926
+745
+5% +$17.5K
DAL icon
97
Delta Air Lines
DAL
$55.4B
$353K 0.26%
6,951
-214
-3% -$9.32K
AVBP icon
98
ArriVent BioPharma
AVBP
$1.55B
$353K 0.26%
15,000
-71,000
-83% -$1.61M
CHRS icon
99
Coherus Oncology
CHRS
$216M
$343K 0.26%
330,000
-670,000
-67% -$919K
VRDN icon
100
Viridian Therapeutics
VRDN
$1.99B
$341K 0.25%
15,000
+2,500
+20% +$40.9K
2 3
4
5 6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, AlphaCentric Advisors held 245 positions worth $135M, down 0.95% from $136M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

AlphaCentric Advisors withdrew a net $11.4M in Q3 2024, closing 15 positions and reducing 140 holdings. Its most notable exit was BioCryst Pharmaceuticals, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 60% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Merck worth $2.73M.

  • AlphaCentric Advisors's largest Q3 2024 buy was Merck: 24,000 shares worth $2.73M.
  • AlphaCentric Advisors added most to Neurocrine Biosciences in Q3 2024, an estimated $2.12M increase.
  • AlphaCentric Advisors's biggest Q3 2024 reduction was Pfizer, cutting an estimated $3.06M.
  • AlphaCentric Advisors fully exited BioCryst Pharmaceuticals in Q3 2024, selling an estimated $4.17M.
  • AlphaCentric Advisors's ten largest holdings make up 21% of its $135M portfolio in Q3 2024.
  • AlphaCentric Advisors opened 28 new positions and closed 15 in Q3 2024.
  • AlphaCentric Advisors's portfolio value fell 0.95% quarter-over-quarter to $135M.

Based on AlphaCentric Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.